HIGHLIGHTS
- who: Sudhir A. Kulkarni et al. from the Fujita Health University, Japan have published the Article: Novel topical esmolol hydrochloride improves wound healing in diabetes by inhibiting aldose reductase, generation of advanced glycation end products, and facilitating the migration of fibroblasts, in the Journal: (JOURNAL)
- what: This study reports the preclinical development and effect of a novel topical formulation of esmolol hydrochloride (Galnobax) for the treatment of DFU. The animal study protocol was approved by the animal research institute committee (IACUC of Bio-Quant Inc., approval number A/102/Q), and all experiments described in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.